Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia
Public ClinicalTrials.gov record NCT01147341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response By Switching to Certolizumab Pegol (Cimzia)? A Phase IV, Randomized, Multi-Center, Double-Blind, Twelve-Week Study Followed by a 12-Week Open-Label Phase
Study identification
- NCT ID
- NCT01147341
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Michael Schiff, MD
- Individual
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Interventions
- Cimzia Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Dec 31, 2011
- Completion
- Dec 31, 2011
- Last update posted
- Jun 8, 2014
2010 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates of N. Alabama | Huntsville | Alabama | 35801 | — |
| Sun Valley Arthritis Center, Ltd. | Peoria | Arizona | 85381 | — |
| Arizona Arthritis and Rhematolgy Research | Phoenix | Arizona | 85037 | — |
| Sarasota Arthritis Research Center | Sarasota | Florida | 34239 | — |
| Physician Research Collaboration, LLC | Lincoln | Nebraska | 68516 | — |
| Westroads Medical Group | Omaha | Nebraska | 68114 | — |
| Morristown Memorial Hospital | Morristown | New Jersey | 07960 | — |
| Buffalo Rheumatology | Orchard Park | New York | 14127 | — |
| Rheumatology Associates of Long Island | Smithtown | New York | 11787 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Mountain State Clinical Research | Clarksburg | West Virginia | 26301 | — |
| Rheumatology and Immunotherapy Center | Oak Creek | Wisconsin | 53154 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01147341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2014 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01147341 live on ClinicalTrials.gov.